WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM
C10 LIPID MODIFYING AGENTS

The DDDs are based on the treatment of hypercholesterolemia.


C10A LIPID MODIFYING AGENTS, PLAIN

Combinations of different cholesterol and triglyceride reducers are classified at separate 5th levels using the corresponding 50-series. The following ranking according to the ATC codes is used: Substances classified in ATC-group C10AA take precedence over C10AB etc.

Pantethine, which is also used in the treatment of hyperlipidemi, is classified as a vitamin in A11HA.


C10AX Other lipid modifying agents

This group comprises all cholesterol and triglyceride reducers, which cannot be classified in the preceding groups.

Sulodexide is classified in B01AB.


    ATC code  Name  DDD  U Adm.R Note
    C10AX03  tiadenol    

List of abbreviations

Last updated: 2013-12-19